why is tirzepatide being discontinued FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease tirzepatide being discontinued In a

Conversely, point estimates for tirzepatide showed a potential modest advantage for heart failure endpoints, with CIs compatible with no difference, consistent with recent data supporting protective effects of semaglutide and tirzepatide on heart failure outcomes and a potential incremental benefit with the latter 22

I just feel way more comfortable in myself. Verified Patient Tara O

All currently available GLP-1 receptor agonists (GLP-1RAs) are, however, injectable

Research suggests that daily astaxanthin supplementation is generally well tolerated and may support skin health, exercise recovery, antioxidant protection, and healthy aging